Holen Sie sich die Stockscreener-App
1.465
8.44%
-0.135
Handel nachbörslich:
1.47
0.005
+0.34%
Schlusskurs vom Vortag:
$1.60
Offen:
$1.7
24-Stunden-Volumen:
116.08K
Relative Volume:
0.99
Marktkapitalisierung:
$57.95M
Einnahmen:
$63.15M
Nettoeinkommen (Verlust:
$-40.30M
KGV:
-0.8772
EPS:
-1.67
Netto-Cashflow:
$-44.47M
1W Leistung:
-13.82%
1M Leistung:
-26.75%
6M Leistung:
-43.65%
1J Leistung:
-52.59%
1-Tages-Spanne:
$1.41
$1.70
1-Wochen-Bereich:
$1.40
$2.1399
52-Wochen-Spanne:
$0.8645
$3.26
Tela Bio Inc Stock (TELA) Company Profile
Firmenname
Tela Bio Inc
Sektor
Branche
Telefon
484-320-2930
Adresse
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Vergleichen Sie TELA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
1.465 | 63.29M | 63.15M | -40.30M | -44.47M | -1.67 |
|
ABT
Abbott Laboratories
|
129.40 | 228.03B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.50 | 152.09B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
378.95 | 143.98B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.91 | 117.98B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.68 | 45.17B | 5.69B | 1.41B | 577.90M | 6.95 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-21 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-05-31 | Eingeleitet | Lake Street | Buy |
| 2019-12-03 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-12-03 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2019-12-03 | Eingeleitet | Jefferies | Buy |
| 2019-12-03 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Tela Bio Inc Aktie (TELA) Neueste Nachrichten
TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates - MSN
Tela Bio at Canaccord Conference: Strategic Growth in Soft Tissue Repair - Investing.com Canada
Tela Bio reiterates $85M–$88M 2025 revenue target as international expansion accelerates - MSN
TELA Bio Awards Inducement Equity Grants to New Employees - MSN
Will TELA Bio Inc. stock benefit from AI tech trendsSwing Entry Risk Mitigation with Chart Analysis - Newser
TELA Bio Inc. stock trend forecastDaily Breakout List with Smart Filters - Newser
Tools to assess TELA Bio Inc.’s risk profileAI Stock Movement Forecast with Accuracy - Newser
Can trapped investors hope for a rebound in TELA Bio Inc.Free Strong Buy With Technical Confidence - Newser
Tela Bio shares fall 6.88% after-hours following inducement grants to new employees. - AInvest
TELA Bio 2025 Q2 Earnings Net Loss Narrows Amid Revenue Growth - AInvest
TELA Bio Reports Strong Q2 2025 Financial Results - MSN
Is TELA Bio Inc. forming a bottoming baseRetirement Investment Outlook and Return Summary - Newser
TELA Bio Inc (TELA) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... - Yahoo Finance
TELA Bio Inc (TELA) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... By GuruFocus - Investing.com Canada
TELA Bio Reports Strong Q2 2025 Growth - TipRanks
TELA Bio Reports Second Quarter 2025 Financial Results - GlobeNewswire
TR | OpenAI4o Maintains TELA Bio(TELA.US) With Hold Rating, Maintains Target Price $2 - 富途牛牛
TELA Bio’s Revenue Climbed But Fell Short Of Expectations - Finimize
Contradictions Unveiled: TELA Bio's Q2 2025 Earnings Call Highlights Shifts in Sales Strategy, Product Growth, and Pricing Positioning - AInvest
Tela Bio (TELA): A Compelling Post-Earnings Case for Long-Term Value Creation in a High-Growth MedTech Sector - AInvest
Tela Bio's 2025 Revenue Guidance and Global Expansion: A Strategic Inflection Point for Scalable Growth - AInvest
Earnings call transcript: Tela Bio Q2 2025 sees stock rise despite EPS miss - Investing.com Canada
Tela Bio earnings missed by $0.04, revenue fell short of estimates - Investing.com Canada
Intraday pattern recognizer results for TELA Bio Inc.Daily Stock Watch Summary with Key Insights - Newser
TELA Bio's Q2 Revenue Miss: A Crossroads of Short-Term Pressures and Long-Term R&D Promise in Biotech - AInvest
TELA Bio misses Q2 revenue estimates - MarketScreener
What machine learning models say about TELA Bio Inc.Predicted Market Direction Based on Momentum - Newser
How to use a screener to detect TELA Bio Inc. breakoutsHigh Probability Trade Outcome Prediction - Newser
Is TELA Bio Inc. Stock Overbought or Oversold RSI Indicator AnalysisAI Generated Momentum Stock Forecast Guide - Newser
Using flow based indicators on TELA Bio Inc.Technical Safety Zone Pattern Recognition - Newser
Published on: 2025-08-09 23:56:57 - Newser
TELA Bio (TELA) Projected to Post Earnings on Monday - Defense World
TELA Bio's Equity Strategy: Balancing Talent Retention and Shareholder Value in the MedTech Sector - AInvest
TELA Bio Inc Q2 2025 Earnings Report Preview: Revenue Expected to Reach $20.68 Million, Earnings at -$0.18 per Share. - AInvest
TELA Bio Grants Inducement Stock Units to New Employees - AInvest
TELA Bio TELA 2025Q2 Earnings Preview Upside Potential Driven by Product Expansion - AInvest
TELA Bio Inc expected to post a loss of 18 cents a shareEarnings Preview - TradingView
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
TELA Bio Strengthens Team with 10,200 Share Incentive Package for 14 Strategic New Hires - Stock Titan
TELA Bio Inc (TELA) Q2 2025 Earnings Report Preview: What To Expect - Yahoo Finance
Finanzdaten der Tela Bio Inc-Aktie (TELA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.31%
1.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):